Experience and Acceptability of Medical Abortion with Mifepristone and Misoprostol Among U.S. Women

By Beckman L.J.   Harvey S.M.  

Women's Health Issues, Vol. 7, Iss. 4, 1997-07 ,pp. : 253-262

Elsevier

Access to resources Recommend Favorite

Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine: Results of two clinical trials

By Raghavan Sheila  

The European Journal of Contraception and Reproductive Health Care, Vol. 18, Iss. 2, 2013-04 ,pp. : 112-119

Informa Healthcare

Access to resources Recommend Favorite

Medical abortion: the Australian experience

By de Costa Caroline  

Expert Review of Obstretrics and Gynecology, Vol. 7, Iss. 1, 2012-01 ,pp. : 25-30

Informa Healthcare

Access to resources Recommend Favorite

Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: Evidence from Uzbekistan

By Raghavan Sheila  

The European Journal of Contraception and Reproductive Health Care, Vol. 18, Iss. 2, 2013-04 ,pp. : 104-111

Informa Healthcare

Access to resources Recommend Favorite

An overview of medical abortion using low-dose mifepristone and misoprostol

By Mathur Manisha   Ashok Premila  

Expert Review of Obstretrics and Gynecology, Vol. 2, Iss. 3, 2007-05 ,pp. : 371-378

Informa Healthcare

Access to resources Recommend Favorite